{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:44:03Z","timestamp":1793382243760,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100020622","name":"Translational Health Science and Technology Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jcehepatology.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jceh.2024.102463","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T08:25:58Z","timestamp":1733214358000},"page":"102463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Liver Organoids From Hepatocytes of Healthy Humans and Non-alcoholic Fatty Liver Disease (NAFLD) Patients Display Multilineage Architecture and can be Used to Develop an In\u00a0Vitro Model of Steatohepatitis"],"prefix":"10.1016","volume":"15","author":[{"given":"Yamini","family":"Goswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Baghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phulwanti K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2024.102463_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102463_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.stemcr.2016.12.020","article-title":"Human induced pluripotent stem cell-derived macrophages share ontogeny with MYB-independent tissue-resident macrophages","volume":"8","author":"Buchrieser","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jceh.2024.102463_bib3","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.102463_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A\u00a0phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2024.102463_bib5","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1177\/1535370216657448","article-title":"Cell sources for In\u00a0Vitro human liver cell culture models","volume":"241","author":"Zeilinger","year":"2016","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.jceh.2024.102463_bib6","first-page":"III","article-title":"Cooperation of liver cells in health and disease","volume":"161","author":"Kmiec","year":"2001","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"10.1016\/j.jceh.2024.102463_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10561-017-9641-6","article-title":"The isolation of primary hepatocytes from human tissue: optimising the use of small non-encapsulated liver resection surplus","volume":"18","author":"Green","year":"2017","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.jceh.2024.102463_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jcmgh.2020.09.016","article-title":"Controversies surrounding the origin of hepatocytes in adult livers and the In\u00a0Vitro generation or propagation of hepatocytes","volume":"11","author":"Pek","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.102463_bib9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jhep.2019.06.030","article-title":"Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids","volume":"71","author":"Mun","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.102463_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119823","article-title":"Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model","volume":"237","author":"Elbadawy","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jceh.2024.102463_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.666138","article-title":"Animal and organoid models of liver fibrosis","volume":"12","author":"Bao","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jceh.2024.102463_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5966\/sctm.2015-0152","article-title":"Concise review: organoids are a powerful tool for the study of liver disease and personalized treatment design in humans and animals","volume":"5","author":"Nantasanti","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jceh.2024.102463_bib13","first-page":"e6","article-title":"Recent advances in liver organoids and their use in In\u00a0Vitro modeling of non-alcoholic fatty liver disease","volume":"2","author":"Chi","year":"2022","journal-title":"Organ"},{"key":"10.1016\/j.jceh.2024.102463_bib14","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.7150\/ijbs.85145","article-title":"Customized liver organoids as an advanced In\u00a0Vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases","volume":"19","author":"Han","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jceh.2024.102463_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/rme.13.39","article-title":"Lgr5(+) liver stem cells, hepatic organoids and regenerative medicine","volume":"8","author":"Huch","year":"2013","journal-title":"Regen Med"},{"key":"10.1016\/j.jceh.2024.102463_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2023.105728","article-title":"3D muli-cell-type liver organoids: a new model of non-alcoholic fatty liver disease for drug safety assessments","volume":"94","author":"Bronsard","year":"2024","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.jceh.2024.102463_bib17","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/acsbiomaterials.0c00682","article-title":"Modeling human nonalcoholic fatty liver disease (NAFLD) with an organoids-on-a-chip system","volume":"6","author":"Wang","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.jceh.2024.102463_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures In\u00a0Vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2024.102463_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2009.11.013","article-title":"Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units In\u00a0Vitro","volume":"6","author":"Barker","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jceh.2024.102463_bib20","volume":"802181","author":"Rossi","year":"2019","journal-title":"Embryonic organoids recapitulate early heart organogenesis"},{"key":"10.1016\/j.jceh.2024.102463_bib21","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.15252\/embj.201694700","article-title":"Self-organized developmental patterning and differentiation in cerebral organoids","volume":"36","author":"Renner","year":"2017","journal-title":"EMBO J"},{"key":"10.1016\/j.jceh.2024.102463_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature13863","article-title":"Modelling human development and disease in pluripotent stem-cell-derived gastric organoids","volume":"516","author":"McCracken","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2024.102463_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.101079","article-title":"Normal and tumor-derived organoids as a drug screening platform for tumor-specific drug vulnerabilities","volume":"3","author":"Calandrini","year":"2022","journal-title":"STAR Protoc"},{"key":"10.1016\/j.jceh.2024.102463_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60747","article-title":"Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma","volume":"10","author":"De Crignis","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jceh.2024.102463_bib25","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41587-023-01680-4","article-title":"Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis","volume":"41","author":"Hendriks","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jceh.2024.102463_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/a-1934-5588","article-title":"Three-dimensional organoids as a model to study nonalcoholic fatty liver disease","volume":"42","author":"Park","year":"2022","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2024.102463_bib27","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/hep.31857","article-title":"Functional characterization of organoids derived from irreversibly damaged liver of patients with NASH","volume":"74","author":"McCarron","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.102463_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MCG.0b013e3181dd1348","article-title":"Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease","volume":"45","author":"Juluri","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2024.102463_bib29","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3727\/096368911X600939","article-title":"Development and application\u00a0of purified tissue dissociation enzyme mixtures for human\u00a0hepatocyte isolation","volume":"21","author":"Gramignoli","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jceh.2024.102463_bib30","article-title":"Amnion-derived mesenchymal stromal\/stem cell paracrine signals potentiate human liver organoid differentiation: translational implications for liver regeneration","volume":"8","author":"Lo","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jceh.2024.102463_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41422-018-0103-x","article-title":"Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens","volume":"29","author":"Fu","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.jceh.2024.102463_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature11826","article-title":"In\u00a0vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration","volume":"14","author":"Huch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2024.102463_bib33","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2018.11.013","article-title":"Long-term expansion of functional mouse and human hepatocytes as 3D organoids","volume":"175","author":"Hu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jceh.2024.102463_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jhep.2018.09.007","article-title":"Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells","volume":"70","author":"Kim","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.102463_bib35","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.stem.2018.10.018","article-title":"In\u00a0vitro expansion of primary human hepatocytes with efficient liver repopulation capacity","volume":"23","author":"Zhang","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jceh.2024.102463_bib36","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1172\/JCI43267","article-title":"Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice","volume":"120","author":"Espejel","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2024.102463_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature12271","article-title":"Vascularized and functional human liver from an iPSC-derived organ bud transplant","volume":"499","author":"Takebe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2024.102463_bib38","doi-asserted-by":"crossref","first-page":"861 1084","DOI":"10.1111\/liv.13634","article-title":"Dual PPARalpha\/gamma agonist saroglitazar improves liver 860 histopathology and biochemistry in experimental NASH models","volume":"38","author":"Jain","year":"2018","journal-title":"Liver Int"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324011307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324011307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T22:50:06Z","timestamp":1746226206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688324011307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0973688324011307"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2024.102463","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Organoids From Hepatocytes of Healthy Humans and Non-alcoholic Fatty Liver Disease (NAFLD) Patients Display Multilineage Architecture and can be Used to Develop an In\u00a0Vitro Model of Steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2024.102463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102463"}}